Nabil Shabshab - 01 Sep 2023 Form 4 Insider Report for Inogen Inc (INGN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Sep 2023, 18:23:26 UTC
Prior SEC filing
05 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Leslyn Cicekli, as Attorney-in-Fact

Key filing fact

Nabil Shabshab filed Form 4 for Inogen Inc (INGN) on 05 Sep 2023.

Key facts

  • This page summarizes Nabil Shabshab's Form 4 filing for Inogen Inc (INGN).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 05 Sep 2023, 18:23.

Change

  • Previous filing in this sequence was filed on 05 Jun 2023.
  • Current net transaction value: -$12,002.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INGN transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+3,686
Change %
+10%
Price
$0.000000
Shares after
38,933
Date
01 Sep 2023
Ownership
Direct
INGN transaction

Common Stock

Tax liability

Transaction value
$12,002
Shares
-1,942
Change %
-5%
Price
$6.18
Shares after
36,991
Date
01 Sep 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-1,569
Change %
-25%
Price
$0.000000
Shares after
4,704
Date
01 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,569
Exercise price
Footnotes
F2, F3
INGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-2,117
Change %
-33%
Price
$0.000000
Shares after
4,234
Date
01 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,117
Exercise price
Footnotes
F2, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2023.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

Footnote F3

Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years.

Footnote F4

Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .